Lack of CTGF*-945c/G dimorphism in Thai patients with systemic sclerosis

Open Rheumatology Journal

Volumn 5, Issue 1, 2011, Pages 59-63

  Louthrenoo, Worawit ^a   Kasitanon, Nuntana ^a   Wichainun, Ramjai ^a   Wangkaew, Suparaporn ^a   Sukitawut, Waraporn ^a   Ohnogi, Yuka ^b   Kuwata, Shoji ^c   Takeuchi, Fujio ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Connective tissue growth factor; Gene; Genetic; Polymorphism; Scleroderma

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYTOSINE; GUANOSINE; OLIGONUCLEOTIDE; PRIMER DNA; RIBONUCLEOPROTEIN; SCL 70 ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LUNG FIBROSIS; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEX DIFFERENCE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; THAI; THORAX RADIOGRAPHY;

EID: 80555134700     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901105010059     Document Type: Article

References (19)

1. Varga J, Denton CP. Systemic sclerosis and the sclerodermaspectrum disorders. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, Eds. Kelley's textbook of rheumatology. Philadelphia: Saunders Elsevier 2009: pp. 1311-51.
2. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008; 34: 17-40; v.
3. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
4. Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis. J Med Assoc Thai 2002; 85: 1204-9.
5. Karassa FB, Ioannidis JP. Mortality in systemic sclerosis. Clin Exp Rheumatol 2008; 26: S85-93.
6. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008; 19: 133-44.
7. Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009; 48(Suppl 3): iii3-7.
8. Leask A, Denton CP, Abraham DJ. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol 2004; 122: 1-6.
9. Fonseca C, Lindahl GE, Ponticos M, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007; 357: 1210-20.
10. Kawaguchi Y, Ota Y, Kawamoto M, et al. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis 2009; 68: 1921-4.
11. Gourh P, Mayes MD, Arnett FC. CTGF polymorphism associated with systemic sclerosis. N Engl J Med 2008; 358: 308-9; author reply 9.
12. Rueda B, Simeon C, Hesselstrand R, et al. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis 2009; 68: 1618-20.
13. Granel B, Argiro L, Hachulla E, et al. Association between a CTGF gene polymorphism and systemic sclerosis in a French population. J Rheumatol 2010; 37: 351-8.
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
15. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
16. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461-6.
17. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917-28.
18. de Winter P, Leoni P, Abraham D. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008; 26: 80-91.
19. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-54.